Crocs, Inc.
CROX
$120.38
-1.51%
Crocs, Inc. designs, develops, markets, and distributes casual lifestyle footwear and accessories for men, women, and children, operating through its Crocs Brand and HEYDUDE Brand segments. As a dominant player in the global clogs and casual footwear market, Crocs has built a distinctive brand identity known for its iconic foam clogs and collaborations with high-profile designers and celebrities. The current investor narrative centers on the company's efforts to revitalize the struggling HEYDUDE brand, which has been a drag on overall growth, while the core Crocs brand continues to show resilience. Recent analyst upgrades and optimism about the HeyDude turnaround plan have fueled interest, but the brand's recovery remains a key overhang on the stock.…
CROX
Crocs, Inc.
$120.38
Related headlines
Investment Opinion: Should I buy CROX Today?
Rating: Buy. CROX is a compelling value opportunity with a forward P/E of 8.18x, a 63% discount to the industry average, and a consensus Buy rating with an average target of $138.25, implying 13.1% upside. The core Crocs brand remains profitable with a 56.75% gross margin, and TTM FCF of $670.7M supports the balance sheet. However, the HeyDude turnaround is the key risk; if it fails, the stock could fall to the low target of $95. This Buy is contingent on HeyDude showing sequential improvement, and would be downgraded to Hold if revenue growth remains negative or if the forward P/E expands above 12x without corresponding earnings growth.
Sign up to view all
CROX 12-Month Price Forecast
The AI model assesses CROX as bullish with medium confidence. The valuation is compelling, and the core brand's profitability provides a floor. However, the HeyDude overhang and recent revenue decline temper confidence. If HeyDude shows improvement in the next two quarters, the stance would upgrade to high confidence; conversely, a continued decline would shift to neutral or bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crocs, Inc.'s 12-month outlook, with a consensus price target around $138.25 and implied upside of +14.8% versus the current price.
Average Target
$138.25
0 analysts
Implied Upside
+14.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$95 - $163
Analyst target range
Crocs is covered by 12 analysts, with a consensus recommendation of 'Buy' and an average target price of $138.25. This implies an upside of approximately 13.1% from the current price of $122.23. The recommendation breakdown shows a mean rating of 2.33 (where 1 is Strong Buy and 5 is Sell), indicating a generally bullish sentiment. Recent ratings actions include upgrades from Piper Sandler (Overweight) and Baird (Outperform), while Goldman Sachs maintains a Sell, reflecting some divergence in views. The target price range spans from a low of $95.00 to a high of $163.00, with the high target implying a 33.3% upside and the low target implying a 22.3% downside. The wide spread of $68 suggests significant uncertainty about the company's future, likely centered on the HeyDude brand's recovery trajectory. The high target likely assumes a successful turnaround and multiple expansion, while the low target may price in continued weakness in HeyDude and potential margin compression. Overall, the consensus leans bullish, but the range highlights the risk-reward tradeoff inherent in the stock.
Bulls vs Bears: CROX Investment Factors
CROX presents a classic value-versus-turnaround debate. The bull case rests on a deeply discounted valuation (8.2x forward P/E), a resilient core Crocs brand, and strong cash generation, while the bear case centers on the struggling HeyDude brand, recent revenue decline, and high leverage. Currently, the evidence slightly favors the bulls: the low P/E provides a margin of safety, and analyst upgrades suggest improving sentiment. However, the single most important tension is whether HeyDude can return to growth—if it does, the stock could re-rate significantly; if not, the discount may persist or widen. The next few quarters will be critical in resolving this debate.
Bullish
- Deep Value at 8.2x Forward P/E: CROX trades at a forward P/E of 8.18x, a 63% discount to the industry average of ~22x. This low multiple, combined with a PEG of 0.52, suggests the market is pricing in minimal growth, offering a margin of safety if HeyDude stabilizes.
- Analyst Consensus Buy with 13% Upside: 12 analysts rate CROX a Buy with an average target of $138.25, implying 13.1% upside from $122.23. Recent upgrades from Piper Sandler and Baird reflect growing confidence in the HeyDude turnaround, while the high target of $163 suggests 33% potential.
- Core Crocs Brand Remains Resilient: The Crocs Brand segment generated $767.4M in Q1 2026, 83.3% of total revenue, with gross margins holding at 56.75%. Despite overall revenue dipping 1.69%, the core brand's stability provides a solid foundation for the HeyDude recovery.
- Strong Profitability and Cash Flow: Q1 2026 net margin improved to 14.9% (net income $137.6M), and trailing twelve-month free cash flow stands at $670.7M. This cash generation supports debt reduction and potential buybacks, enhancing shareholder value.
Bearish
- HeyDude Brand Remains a Drag: HeyDude contributed only $154.0M in Q1 2026 (16.7% of revenue) and is the primary cause of the 1.69% YoY revenue decline. The brand's recovery is uncertain, and continued weakness could keep pressuring overall growth and margins.
- Revenue Decline Breaks Growth Streak: Q1 2026 revenue fell 1.69% YoY to $921.5M, breaking a streak of growth. This deceleration raises concerns about demand, especially in discretionary categories, and could signal further softness if HeyDude doesn't improve.
- High Leverage and Negative FCF in Quarter: Debt-to-equity stands at 1.25, indicating moderate leverage, and Q1 free cash flow was -$71.1M due to working capital swings. While TTM FCF is positive, the quarterly negative FCF could limit financial flexibility if the downturn persists.
- Elevated Volatility and Overextension Risk: With a beta of 1.526, CROX is 53% more volatile than the market. After a 41.65% run, the stock sits near its 52-week high, and a pullback could be sharp; the 1-month decline of -8.46% already shows sensitivity to sentiment shifts.
CROX Technical Analysis
Crocs has been in a strong uptrend over the past year, with the stock price up 41.65% over the last 12 months. Currently trading at $122.23, the stock is positioned at approximately 86.5% of its 52-week range (between $73.21 low and $141.28 high), indicating it is closer to the highs than the lows. This positioning suggests robust momentum, though it also raises the risk of overextension, especially after a recent pullback from the peak. The stock's beta of 1.526 indicates it is about 53% more volatile than the broader market, amplifying both upside and downside moves.
Beta
1.53
1.53x market volatility
Max Drawdown
-30.5%
Largest decline past year
52-Week Range
$73-$141
Price range past year
Annual Return
+38.1%
Cumulative gain past year
| Period | CROX Return | S&P 500 |
|---|---|---|
| 1m | -6.0% | +2.7% |
| 3m | +3.0% | +1.0% |
| 6m | +44.0% | +12.0% |
| 1y | +38.1% | +18.9% |
| ytd | +38.4% | +12.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CROX Fundamental Analysis
In the most recent quarter (Q1 2026), Crocs reported revenue of $921.5 million, a slight decline of 1.69% year-over-year, breaking a streak of growth seen in prior quarters. The revenue mix shows the Crocs Brand segment contributing $767.4 million (83.3% of total) and HEYDUDE Brand contributing $154.0 million (16.7%), with the latter being the primary drag on growth. Gross margin remained healthy at 56.75%, while operating margin came in at 21.8%, reflecting solid cost control despite the revenue dip. Net income for the quarter was $137.6 million, translating to a net margin of 14.9%, a significant improvement from the loss recorded in Q2 2025, which was impacted by a one-time impairment charge. The company's balance sheet shows a debt-to-equity ratio of 1.25, indicating moderate leverage, and a current ratio of 1.27, suggesting adequate short-term liquidity. Free cash flow for the quarter was negative at -$71.1 million, primarily due to working capital swings, but trailing twelve-month free cash flow stands at $670.7 million, demonstrating the company's ability to generate cash over the longer term.
Quarterly Revenue
$921457000.0B
2026-03
Revenue YoY Growth
-1.7%
YoY Comparison
Gross Margin
56.8%
Latest Quarter
Free Cash Flow
$670662000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CROX Overvalued?
Given that Crocs has positive net income (TTM net income is positive, with Q1 2026 net income of $137.6 million), the appropriate valuation metric is the P/E ratio. The trailing P/E is -57.01 due to the one-time loss in Q2 2025, which makes it uninformative; therefore, the forward P/E of 8.18 is more relevant. This low forward multiple suggests the market is pricing in modest earnings growth, as the PEG ratio of 0.52 indicates the stock is undervalued relative to its expected growth rate. Compared to the industry average P/E of approximately 22x (based on available data), Crocs trades at a significant discount, with a forward P/E of 8.18x representing a 63% discount. This discount is likely justified by the HeyDude turnaround risk and the recent revenue decline, but it also offers a margin of safety if the brand recovery succeeds. Historically, Crocs' P/E has ranged from as low as 4.28x (Q4 2024) to as high as 15.66x (Q1 2022), and the current forward P/E of 8.18x is near the lower end of that range, suggesting the stock is trading at a historically cheap valuation, which could indicate either a value opportunity or reflect the market's skepticism about future growth.
PE
-57.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a debt-to-equity ratio of 1.25, indicating moderate leverage that could strain cash flows if interest rates remain elevated. The negative free cash flow of -$71.1M in Q1 2026, despite a TTM FCF of $670.7M, highlights working capital volatility that could impact liquidity. Additionally, the net margin of 14.9% in Q1 is an improvement, but the one-time loss in Q2 2025 (net income -$492.3M) shows earnings can be highly volatile, and the trailing P/E of -57 is uninformative, complicating valuation analysis.
FAQ
The key risks are: 1) HeyDude brand underperformance, which could continue to drag revenue and margins; 2) High leverage (debt-to-equity of 1.25) and negative quarterly FCF, which could strain finances; 3) Market volatility (beta of 1.526) and potential valuation compression if growth stalls; 4) Consumer discretionary spending weakness, which could impact sales. The most severe risk is a failed HeyDude turnaround, leading to a decline toward the $95 low target.
The 12-month forecast is mixed but leans positive. The base case (50% probability) sees the stock trading between $125 and $140, near the analyst average of $138.25. The bull case (30% probability) targets $140-$163, assuming HeyDude recovers. The bear case (20% probability) sees $95-$110 if HeyDude deteriorates. The most likely scenario is a gradual stabilization, with the stock appreciating modestly from current levels.
CROX is undervalued relative to its growth prospects. The forward P/E of 8.18x is well below the industry average of 22x, and the PEG ratio of 0.52 suggests the stock is cheap for its expected growth. Historically, the P/E has ranged from 4.28x to 15.66x, and the current level is near the lower end, indicating the market is pricing in significant risk. If HeyDude recovers, the multiple could expand, offering substantial upside.
CROX is a good buy for investors seeking value with a catalyst. The stock trades at a forward P/E of 8.18x, a 63% discount to the industry, and analysts see 13.1% upside to the average target of $138.25. The main risk is HeyDude's continued weakness, which could lead to a 22% downside to the low target of $95. If you believe in the HeyDude turnaround, the risk/reward is attractive; otherwise, it's a speculative value play.
CROX is better suited for long-term investors with a 2-3 year horizon, given the HeyDude turnaround is a multi-quarter process. The stock's beta of 1.526 makes it volatile for short-term trading, but the low valuation and strong cash flow provide a foundation for long-term appreciation. Short-term traders could profit from momentum, but the risk of sharp pullbacks is high. For most investors, a long-term approach aligns with the potential for value realization.